img
APOBEC3B expression in drug resistant MCF 7 breast cancer cell lines     
Yazarlar
Önder Öngürü
Sağlık Bilimleri Üniversitesi, Türkiye
Prof. Dr. Serap YALÇIN AZARKAN
Ahi Evran Üniversitesi, Türkiye
Cinthia Rosemblit
Paul Zhang
Selim Kılıç
Sağlık Bilimleri Üniversitesi, Türkiye
Ufuk Gündüz
Orta Doğu Teknik Üniversitesi, Türkiye
Özet
APOBEC3B belongs to a protein family of cytidine deaminases that can insert mutations in DNA and RNA as a result of their ability to deaminate cytidine to uridine. It has been shown that APOBEC3B-catalysed deamination provides a chronic source of DNA damage in breast cancers. We investigated APOBEC3B expression in four drug resistant breast cancer cell lines (Doxorubicin, Etoposide, Paclitaxel and Docetaxel resistant MCF-7 cell lines) using a novel RNA in situ hybridization technology (RNAscope) and compared expression levels with drug sensitive MCF-7 cell line. After RNAscope staining, slides were scanned and saved as digital images using Aperio scanner and software. Quantitative scoring utilizing the number of punctate dots present within each cell boundary was performed for the parameters including positive cell percentage and signal intensity per positive cell. In Doxorubicin and Etoposide resistant MCF-7 cell lines, APOBEC3B expression was approximately five-fold increased (23% and 24% respectively) with higher signal intensity (1.92 and 1.44 signal/cell, respectively) compared to drug sensitive MCF-7 cell line (5%, 1.00 signal/cell) with statistical significance. The increase of APOBEC3B expression in Docataxel resitant and Paclitaxel resistant MCF-7 cell lines was not very high. In conclusion, APOBEC3B expression was increased in some population of tumor cells of drug resistant cell lines. At least for some drugs, APOBEC3B expression may be related to drug resistance, subjecting to some tumor cells to frequent mutation. (C) 2016 Elsevier Masson SAS. All rights reserved.
Anahtar Kelimeler
APOBEC3B, Drug resistant, MCF-7, Breast cancer
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı Biomedicine & Pharmacotherapy
Dergi ISSN 0753-3322
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce
Basım Tarihi 04-2016
Cilt No 79
Sayfalar 87 / 92
Doi Numarası 10.1016/j.biopha.2016.02.004
Makale Linki http://linkinghub.elsevier.com/retrieve/pii/S0753332216301056
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
WoS 3
Google Scholar 12
APOBEC3B expression in drug resistant MCF 7 breast cancer cell lines

Paylaş